The heavier the person, the lower the chance of getting hospice care or dying at home

February 06, 2017

ANN ARBOR, MI - The heavier someone is, the less likely they are to have what many people might call a "good death", with hospice care and a chance to die at home, a new study finds. And that difference comes with a financial, as well as a personal, cost, the research shows.

A new study done at the University of Michigan Institute for Healthcare Policy and Innovation and published in the Annals of Internal Medicine draws this conclusion from an in-depth analysis of records from more than 5,600 senior citizens taking part in a long-term health study.

The researchers looked at how the seniors' body mass index or BMI - a measure of obesity -- related to end-of-life measures such as their use of hospice services, which provide supportive care to people in their final months of life.

The higher someone's BMI, the less likely they were to enter hospice at all, the researchers found. And for those seniors who did use hospice services at the end of their lives, people with obesity spent fewer days in hospice than those with lower BMIs.

About 60 percent of the seniors in the study died at home - an experience that most Americans say they would choose for their own deaths. But that percentage dropped as BMI rose.

The one thing that was higher among people with higher BMIs was the cost to the Medicare system for the care they received in their last six months of life.

"Obesity is a complex disease, and this study has shown another side of its effect on patients and the healthcare system. Patients with obesity are less likely to receive high quality end-of-life care," says John Harris, M.D., M.Sc., who led the study during a fellowship at U-M and is now an assistant professor at the University of Pittsburgh School of Medicine.

Although the study didn't look at the reasons why people with obesity received less hospice care, senior author Jennifer Griggs, M.D., M.P.H., a professor at the U-M Medical School, suspects that several factors may be involved.

"For hospice teams, as for hospital and home-health teams, it can require more staff to take care of people who are obese, but Medicare hospice reimbursement is capped no matter what a person's BMI," she says. "Also, obesity may mask the signposts and changes that physicians might use to determine when it is time for a person to enter hospice."

Griggs, who treats patients with cancer at the U-M Comprehensive Cancer Center, notes that even in overweight and obese people, it's possible to see the signs of cachexia, or the natural "wasting away" that occurs toward the end of life.

This can include more pronounced cheekbones, collarbones and pelvic bones - but physicians may not notice the gradual changes that occur over time in a heavier person. A major change in body weight is also more noticeable on a leaner person. "To refer a patient for hospice, you have to believe that they are in the dying process," she notes.

Harris and Griggs also note that previous studies have shown a general bias against people with obesity among healthcare professionals, especially physicians. They suspect, but cannot show with the new data, that this may also play a role in the end-of-life care decisions. Griggs also notes that obesity, and the role of obesity as a barrier to optimal care, isn't even mentioned in Dying in America, a landmark 2014 Institute of Medicine report.

The new results, Harris says, suggest that more policy attention should be focused on people with more severe levels of obesity. "These patients' voices, and those of their caregivers, need to be heard," he says. "They may need extra help. They deserve the best healthcare and better health outcomes."

More about the study

The team compiled their results using data from in-depth surveys and Medicare records from 5,677 people enrolled in the long-running, nationally representative Health and Retirement Study. All of the participants whose records they studied died between 1998 and 2012 and were not living long-term in a nursing home.

The researchers focused on Medicare claims in the last six months of the participants' lives, looking at use of hospice services and controlling for gender, race, marital status, multiple medical conditions, and household assets. They also had information from surveys of the participants' loved ones about their end-of-life care. And, they had all participants' last measured BMI, which is weight in kilograms divided by height in meters squared.

Fifteen percent of participants were obese, with BMIs over 30, and 2 percent were morbidly obese, with BMIs over 40. Another 31 percent were overweight, with BMIs between 25 and 29.9.

In all, 38 percent of the entire group used hospice services. But the higher a person's BMI, the lower their chances of getting hospice services. Someone who had a BMI of 40 had less than a 23 percent chance of having hospice services at the end of life, while those in the "normal" weight, with BMI of 20, had a 38 percent chance.

Even among those of any weight who did use hospice services, the number of days spent in hospice was lower among those whose BMIs were higher. The difference stemmed from a stark difference in use of home hospice by heavier people.

Nearly 60 percent of the participants died at home - but people with high BMIs were less likely to.

The differences in end-of-life care translated into differences in cost. In the last six months of life for a person with a BMI of 20, the Medicare system spent about $43,000 for all types of care. But for a person with a BMI of 30, the costs for that same period were about $3,500 higher.

In all, Harris says, the findings point to a larger issue that will become more urgent as the increasingly overweight American population ages. "Many policies focus on preventing or reducing obesity in the US, but we will also need policies to encourage the provision of high-quality care for people with obesity," he says. "More attention should be paid to payment structures that recognize the challenges involved with healthcare for men and women with obesity."

Griggs is leading another research effort - based on a partnership with the state of Michigan and Hospice of Michigan - to look at more aspects of hospice care, including race and caregiver factors.
-end-
The study was funded by the Robert Wood Johnson Foundation, U.S. Department of Veterans Affairs, and National Institutes of Health; the HRS is funded by the National Institute on Aging. Harris is an assistant professor of obstetrics, gynecology and reproductive sciences at Pitt who participated in the Robert Wood Johnson Clinical Scholars Program at U-M. Griggs is a professor of hematology/oncology in the U-M Medical School who also holds a joint appointment at the U-M School of Public Health. Other authors include current and former IHPI members Elena Byhoff, M.D., M.Sc., Chithra Perumalswami, M.D., M.Sc., and Kenneth Langa, M.D., Ph.D. Alexi Wright, M.D, M.P.H., of the Dana Farber Cancer Institute, is a co-author.

Michigan Medicine - University of Michigan

Related Obesity Articles from Brightsurf:

11 years of data add to the evidence for using testosterone therapy to treat obesity, including as an alternative to obesity surgery
New research covering 11 years of data presented at this year's European and International Congress on Obesity (ECOICO 2020) show that, in obese men suffering from hypogonadism (low testosterone), treatment with testosterone injections lowers their weight and improves a wide range of other metabolic parameters.

Overlap between immunology of COVID-19 and obesity could explain the increased risk of death in people living with obesity, and also older patients
Data presented in a special COVID-19 session at the European and International Congress on Obesity (ECOICO 2020) suggests that there are overlaps between the immunological disturbances found in both COVID-19 disease and patients with obesity, which could explain the increased disease severity and mortality risk faced by obese patients, and also elderly patients, who are infected by the SARS-CoV-2 virus that causes COVID-19 disease.

New obesity guideline: Address root causes as foundation of obesity management
besity management should focus on outcomes that patients consider to be important, not weight loss alone, and include a holistic approach that addresses the root causes of obesity, according to a new clinical practice guideline published in CMAJ (Canadian Medical Association Journal) http://www.cmaj.ca/lookup/doi/10.1503/cmaj.191707.

Changing the debate around obesity
The UK's National Health Service (NHS) needs to do more to address the ingrained stigma and discrimination faced by people with obesity, says a leading health psychologist.

Study links longer exposure to obesity and earlier development of obesity to increased risk of type 2 diabetes
Cumulative exposure to obesity could be at least as important as actually being obese in terms of risk of developing type 2 diabetes (T2D), concludes new research published in Diabetologia (the journal of the European Association for the Study of Diabetes [EASD]).

How much do obesity and addictions overlap?
A large analysis of personality studies has found that people with obesity behave somewhat like people with addictions to alcohol or drugs.

Should obesity be recognized as a disease?
With obesity now affecting almost a third (29%) of the population in England, and expected to rise to 35% by 2030, should we now recognize it as a disease?

Is obesity associated with risk of pediatric MS?
A single-center study of 453 children in Germany with multiple sclerosis (MS) investigated the association of obesity with pediatric MS risk and with the response of first-line therapy in children with MS.

Women with obesity prior to conception are more likely to have children with obesity
A systematic review and meta-analysis identified significantly increased odds of child obesity when mothers have obesity before conception, according to a study published June 11, 2019 in the open-access journal PLOS Medicine by Nicola Heslehurst of Newcastle University in the UK, and colleagues.

Obesity medicine association announces major updates to its adult obesity algorithm
The Obesity Medicine Association (OMA) announced the immediate availability of the 2019 OMA Adult Obesity Algorithm, with new information for clinicians including the relationship between Obesity and Cardiovascular Disease, Diabetes Mellitus, Dyslipidemia, and Cancer; information on investigational Anti-Obesity Pharmacotherapy; treatments for Lipodystrophy; and Pharmacokinetics and Obesity.

Read More: Obesity News and Obesity Current Events
Brightsurf.com is a participant in the Amazon Services LLC Associates Program, an affiliate advertising program designed to provide a means for sites to earn advertising fees by advertising and linking to Amazon.com.